Language:
Daily summary of financings for therapeutic biotechnology company executives and investors
Thursday, May 22, 2025
Wednesday, May 21, 2025
Sanofi’s $600 Million Acquisition of Vigil
Paratek’s $330 Million Acquisition of Optinose
Juvenescence’s $76 Million Series B-1
ReproNovo’s $65 Million Series A
CEL-SCI’s $5 Million Public Offering
Protagenic’s $3 Million Warrant Exercise
Tuesday, May 20, 2025
SV Health’s $269 Million Fund Raise
Regenics’s $3 Million Private Placement
AB’s $2 Million Private Placement
Monday, May 19, 2025
Thursday, May 15, 2025
Pathos’s $365 Million Series D
Alpheus’s $52 Million Series B
Atara’s $16 Million Public Offering
Aura’s $12 Million Public Offering
Silo’s $2 Million Public Offering
Wednesday, May 14, 2025
Therini’s $39 Million Series A
Tuesday, May 13, 2025
Axsome’s$570 Million Debt Financing
Azafaros’s $147 Million Series B
Remedy Plan’s $18 Million Venture Financing
CNS’s $5 Million Public Offering
Monday, May 12, 2025
Friday, May 9, 2025
Sirius’s $50 Million Series B2
Apimeds’s $3 Million Public Offering
Thursday, May 8, 2025
HAYA’s $65 Million Series A…More
Wednesday, May 7, 2025
Palatin’s $23 Million Public Offering
Sponsors
In coordination with an executive placement firm that is independent and unaffiliated with Collabrity, Inc., we may coordinate with executive(s) who are sourced by that firm and also independent and unaffiliated with Collabrity, Inc.: “Collabrity Executive(s)” does not imply an employment or independent contractor relationship with Collabrity, Inc.
Securities offered through Finalis Securities LLC Member FINRA / SIPC. Collabrity Inc. is not a registered broker-dealer, and Finalis Securities LLC and Collabrity Inc. are separate, unaffiliated entities. Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck